Abstract
Purpose: In the present study, an attempt is made to understand the pattern of HAIs (Healthcare Associated Infections) [device associated infections such as Catheter Associated Urinary Tract Infection (CAUTI), Ventilator Associated Event (VAE), Central Line-Associated Bloodstream Infection (CLABSI) & Surgical Site Infection (SSI) by analyzing statistical tool of quality indicators] and to establish a bench mark for HAIs in a single hospital for a period of 5 years. Methods: The Microbiologist & ICN’s conduct rounds in ICU’s & wards and collect data for active surveillance. The details of culture positive samples are collected by Microbiologist from the laboratory for passive surveillance. The surveillance forms (active & passive) capture details of individual patients. The data collection forms are prepared and updated as per Centers for Disease Control and Prevention (CDC), National Healthcare Safety Network (NHSN) guidelines. The data is analyzed and presented in the meeting of Hospital Infection Control Committee meeting & discussed with clinicians. Results: The cumulative (5 years) CAUTI rate is 0.45, VAE is 2.42, CLABSI is 1.35 & SSI is 0.21. HAI rates were highest for VAE (2.42/1000 ventilator days), the next was CLABSI (1.35/1000 central line days), followed by CAUTI (0.45/1000 urinary catheter days). SSI rate was 0.21/ 100 surgeries. Conclusions: Before the study was started, the benchmark were 2 for CAUTI, 5.5 for VAE, 3 for CLABSI and 2 for SSI. We could able to reduce the baseline benchmark and established our new benchmark as 1 for CAUTI, 3 for VAE, 2 for CLABSI and 1 for SSI that can be used in developing HAI prevention policies by the institution.
Highlights
Note: If you are following pedVAP in your monthly reporting plan it is not required to monitor for Ventilator-associated pneumonia (VAP) after the patient is discharged from the facility
Healthcare-associated infections (HAI): All NHSN site-specific infections must first meet the HAI definition as defined in Chapter 2 before a site-specific infection can be reported to NHSN
The following pages detail the various criteria that may be used for meeting the surveillance definition of healthcare-associated pneumonia (Tables 1-4 and Figures 1 and 2), general comments applicable to all site-specific criteria, and reporting instructions
Summary
If only one imaging test is available, it is acceptable for this to satisfy the imaging requirement for PNEU/VAP-POA determinations regardless of whether the patient has underlying pulmonary or cardiac disease. When multiple imaging test results are available, persistence of imaging test evidence of pneumonia is a requirement for all patients not just those with underlying cardiac or pulmonary disease. When identifying persistence of imaging test evidence of pneumonia, the second imaging test must occur within seven days of the first but is not required to occur within the Infection Window Period. The date of the first eligible imaging test will be utilized when determining if the PNEU/VAP criteria are met within the infection window period. All other elements of PNEU/VAP definition must be present within the infection window period
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
